Regarding “Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients”

被引：0
|
作者：
Hiu-Fung Yuen
Shu-Dong Zhang
Ashley San-Yu Wong
Cian M. McCrudden
Yu-Han Huang
Kelvin Yuen-Kwong Chan
Mohamed El-Tanani
Ui-Soon Khoo
机构：
[1] Queen’s University of Belfast,Center for Cancer Research and Cell Biology
[2] Queen’s University of Belfast,School of Pharmacy
[3] A*STAR,Institute of Molecular and Cell Biology
[4] The University of Hong Kong,Department of Pathology
来源：
Breast Cancer Research and Treatment | 2012年 / 131卷
关键词：
Breast Cancer Patient; Epithelial Mesenchymal Transition; Nuclear Expression; Short Survival Time; Early Breast Cancer Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：351 / 352
页数：1
相关论文
共 50 条
  • [31] SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer
    Lutfi H. Alfarsi
    Rokaya El Ansari
    Madeleine L. Craze
    Omar J. Mohammed
    Brendah K. Masisi
    Ian O. Ellis
    Emad A. Rakha
    Andrew R. Green
    Breast Cancer Research and Treatment, 2021, 189 : 317 - 331
  • [32] Impact of FOXA1 Expression on the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer
    Yuichi Hisamatsu
    Eriko Tokunaga
    Nami Yamashita
    Sayuri Akiyoshi
    Satoko Okada
    Yuichiro Nakashima
    Shinichi Aishima
    Masaru Morita
    Yoshihiro Kakeji
    Yoshihiko Maehara
    Annals of Surgical Oncology, 2012, 19 : 1145 - 1152
  • [33] Impact of FOXA1 Expression on the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer
    Hisamatsu, Yuichi
    Tokunaga, Eriko
    Yamashita, Nami
    Akiyoshi, Sayuri
    Okada, Satoko
    Nakashima, Yuichiro
    Aishima, Shinichi
    Morita, Masaru
    Kakeji, Yoshihiro
    Maehara, Yoshihiko
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (04) : 1145 - 1152
  • [34] New Strategies in Estrogen Receptor-Positive Breast Cancer
    Johnston, Stephen R. D.
    CLINICAL CANCER RESEARCH, 2010, 16 (07) : 1979 - 1987
  • [35] Geographic excess of estrogen receptor-positive breast cancer
    Benz, CC
    Clarke, CA
    Moore, DH
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (12) : 1523 - 1527
  • [36] Estrogen receptor-positive breast cancer: a multidisciplinary challenge
    Zwart, Wilbert
    Theodorou, Vasiliki
    Carroll, Jason S.
    WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2011, 3 (02) : 216 - 230
  • [37] Risk factors for estrogen receptor-positive breast cancer
    Hwang, ES
    Chew, T
    Shiboski, S
    Farren, G
    Benz, CC
    Wrensch, M
    ARCHIVES OF SURGERY, 2005, 140 (01) : 58 - 62
  • [38] Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer
    Zhang, Xiang H. -F.
    Giuliano, Mario
    Trivedi, Meghana V.
    Schiff, Rachel
    Osborne, C. Kent
    CLINICAL CANCER RESEARCH, 2013, 19 (23) : 6389 - 6397
  • [39] Benefit of paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer - Reply
    Henderson, IC
    Norton, L
    Berry, DA
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4465 - 4466
  • [40] Twist regulates estrogen receptor expression in breast cancer
    Vesuna, Farhad
    Lisok, Ala
    Kimble, Brian
    Domek, John
    Kato, Yoshinori
    Artemov, Dmitri
    Kowalski, Jeanne
    Carraway, Hetty
    van Diest, Paul
    Raman, Venu
    CANCER RESEARCH, 2010, 70
12345